Variation in cancer risk among families with genetic susceptibility.
frailty model
hereditary cancer
risk heterogeneity
Journal
Genetic epidemiology
ISSN: 1098-2272
Titre abrégé: Genet Epidemiol
Pays: United States
ID NLM: 8411723
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
07
01
2020
revised:
26
08
2020
accepted:
28
08
2020
pubmed:
9
10
2020
medline:
21
10
2021
entrez:
8
10
2020
Statut:
ppublish
Résumé
Germline mutations in many genes have been shown to increase the risk of developing cancer. This risk can vary across families who carry mutations in the same gene due to differences in the specific variants, gene-gene interactions, other susceptibility mutations, environmental factors, and behavioral factors. We develop an analytic tool to explore this heterogeneity using family history data. We propose to evaluate the ratio between the number of observed cancer cases in a family and the number of expected cases under a model where risk is assumed to be the same across families. We perform this analysis for both carriers and noncarriers in each family, using carrier probabilities when carrier statuses are unknown, and visualize the results. We first illustrate the approach in simulated data and then apply it to data on colorectal cancer risk in families carrying mutations in Lynch syndrome genes from Creighton University's Hereditary Cancer Center. We show that colorectal cancer risk in carriers can vary widely across families, and that this variation is not matched by a corresponding variation in the noncarriers from the same families. This suggests that the sources of variation in these families are to be found predominantly in variants harbored in the mutated MMR genes considered, or in variants interacting with them.
Identifiants
pubmed: 33030277
doi: 10.1002/gepi.22366
pmc: PMC7902332
mid: NIHMS1633736
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
209-221Subventions
Organisme : NCI NIH HHS
ID : T32 CA009001
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA006516
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009337
Pays : United States
Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Hum Mol Genet. 2012 Feb 15;21(4):958-62
pubmed: 22072393
J Clin Oncol. 2015 Nov 1;33(31):3591-7
pubmed: 26282643
JAMA. 2008 Jan 9;299(2):194-201
pubmed: 18182601
JAMA. 2015 Apr 7;313(13):1347-61
pubmed: 25849179
Hum Hered. 1971;21(6):523-42
pubmed: 5149961
Am J Hum Genet. 1997 May;60(5):1059-67
pubmed: 9150153
Cancer Genet Cytogenet. 1997 Jan;93(1):84-99
pubmed: 9062584
N Engl J Med. 1997 May 15;336(20):1401-8
pubmed: 9145676
Compr Physiol. 2012 Oct;2(4):2775-809
pubmed: 23720265
JAMA. 2006 Sep 27;296(12):1479-87
pubmed: 17003396
Lifetime Data Anal. 2014 Apr;20(2):234-51
pubmed: 23737081
Demography. 1979 Aug;16(3):439-54
pubmed: 510638
Genet Epidemiol. 2020 Sep;44(6):564-578
pubmed: 32506746
Hum Mol Genet. 2010 Jul 15;19(14):2886-97
pubmed: 20418484
J Am Stat Assoc. 2013 Dec 1;108(504):1205-1215
pubmed: 24678132
Int J Cancer. 2018 Nov 1;143(9):2250-2260
pubmed: 29904935
Biostatistics. 2017 Apr 1;18(2):275-294
pubmed: 27756721
Lancet. 2011 Dec 17;378(9809):2081-7
pubmed: 22036019
Arch Intern Med. 1966 Feb;117(2):206-12
pubmed: 5901552
Br J Cancer. 2002 Jan 7;86(1):76-83
pubmed: 11857015
J Natl Cancer Inst. 1994 Nov 2;86(21):1600-8
pubmed: 7932824